Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-na?ve HIV-1-infected individuals

A Pereira; JP Lopes da Cruz; C Carvalho; C Gonaalves; F Antunes

首页> 外文期刊>Journal of the International Aids Society >Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-na?ve HIV-1-infected individuals

【24h】

Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-na?ve HIV-1-infected individuals

机译：包括利托那韦增强的洛匹那韦或奈韦拉平在内的抗逆转录病毒初治HIV-1感染者的疗效和安全性比较

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of the International Aids Society》 |2010年第4期|共页
作者
A Pereira; JP Lopes da Cruz; C Carvalho; C Gonaalves; F Antunes;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类流行病学与防疫;
关键词

相似文献

外文文献
中文文献
专利

1. Impact of Efavirenz-, Ritonavir-Boosted Lopinavir-, and Nevirapine-Based Antiretroviral Regimens on the Pharmacokinetics of Lumefantrine and Safety of Artemether-Lumefantrine in Plasmodium falciparum-Negative HIV-Infected Malawian Adults Stabilized on Antiretroviral Therapy [J] . Banda Clifford G., Dzinjalamala Fraction, Mukaka Mavuto, Antimicrobial agents and chemotherapy. . 2018,第11期

机译：efaviravir-，ritonavir - 增强的洛诺维韦 - 以及Nevirapine的抗逆转录病毒治疗抗逆转录病毒治疗稳定的抗逆转录病毒治疗稳定的抗逆转录病毒治疗中Lumefantrine对Lumefantrine和安全性的药代动力学的影响
2. Efficacy and safety of an NRTI-sparing regimen in antiretroviral-na?ve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir [J] . S Nozza, L Galli, M Di Pietro, Journal of the International Aids Society . 2010,第Suppla4期

机译：抗逆转录病毒初治型HIV感染患者的NRTI保留方案的疗效和安全性：每天一次maraviroc加上lopinavir / ritonavir
3. Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial) [J] . Slama Laurence, Landman Roland, Assoumou Lambert, The Journal of Antimicrobial Chemotherapy . 2016,第8期

机译：每日一次利托那韦增强的阿扎那韦或达那那韦联合双核苷酸类似物主链治疗在HIV-1感染的联合ART（cART）初治严重免疫抑制患者中的疗效和安全性：48周，非对照，随机，多中心试验（IMEA 040 DATA试验）
4. The Two First-Line Recommended Antiretroviral Regimens for Naive HIV-Infected Patients: Efavirenz-Based Versus Lopinavir-Ritonavir-Based Haart [C] . R. Manfredi, L. Calza, F. Chiodo International AIDS Conference . 2004

机译：幼稚艾滋病毒感染患者的两种第一线推荐的抗逆转录病毒方案：efavirenz为基于Lopinavir-Ritonavir的HAART
5. Cost-Effectiveness Analysis of Nevirapine vs. Ritonavir-Boosted Lopinavir in HIV-infected Children With Peripartum Nevirapine Exposure In Resource-Constrained Areas From Payer's Perspective. [D] . Godwin, Onyeka Peter. 2014

机译：从付款人的角度来看，在资源受限地区感染了围产期尼维拉平的HIV感染儿童中，奈韦拉平vs.利托那韦促进洛匹那韦的成本-效果分析。
6. Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naïve HIV-1-infected individuals [O] . A Pereira, JP Lopes da Cruz, C Carvalho, 2010

机译：包括利托那韦增强的洛匹那韦或奈韦拉平在内的方案在未经抗逆转录病毒治疗的HIV-1感染者中的比较疗效和安全性
7. Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naïve HIV-1-infected individuals [O] . A Pereira, JP Lopes da Cruz, C Carvalho, 2010

机译：包括利托那韦增强的洛匹那韦或奈韦拉平在内的方案在未经抗逆转录病毒治疗的HIV-1感染者中的比较疗效和安全性
8. Morbidity and Mortality Weekly Report, Vol. 49, No. 51 and No. 52, January 5,2001. Serious Adverse Events Attributed to Nevirapine Regimens for Postexposure Prophylaxis After HIV Exposures: Worldwide, 1997-2000 [R] . 2001

机译：发病率和死亡率周报，Vol。 2001年1月5日第49号，第51号和第52号。严重不良事件归因于奈韦拉平方案在艾滋病毒暴露后进行暴露后预防：全球，1997-2000

Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-na?ve HIV-1-infected individuals

著录项

相似文献

相关主题

期刊订阅